The Company has an equity incentive plan, the Amended and Restated 2014 Stock Incentive Plan (the “2014 Plan”), which provides for the granting of non-qualified and incentive stock options, restricted stock and restricted stock units, stock appreciation rights and other awards to employees, directors and consultants. The Company also has an employment agreement with its Chief Executive Officer that provides for an award of restricted stock units. For additional information regarding the Company’s stock-based compensation plans, see Note 16—“Stock-Based Compensation” in the 2024 Form 10-K.

At March 31, 2025, 1,007,365 shares of common stock were authorized for future awards under the 2014 Plan. As of March 31, 2025, the total compensation cost not yet recognized related to non-vested awards was $74.8 million, which is expected to be recognized over a weighted-average period of 1.4 years.


	RSUs	Weighted-Average Grant-Date Fair Value
Non-vested balance at June 30, 2024	1,541,194	$	43.95
Granted	1,006,449	64.46
Vested	(592,005)	43.48
Forfeited	(71,433)	47.62
Non-vested balance at March 31, 2025	1,884,205	$	54.92

The total fair value of shares vested for the three and nine months ended March 31, 2025 was $15.7 million and $38.8 million, respectively. The total fair value of shares vested for the three and nine months ended March 31, 2024 was $10.3 million and $25.2 million, respectively.


	For the Three Months Ended March 31,				For the Nine Months Ended March 31,
(Dollars in thousands except per share data)	2025		2024		2025		2024
Total repurchase	$	27,870	$	595	$	27,870	$	83,781
Number of shares repurchased	434,327		12,101		434,327		2,267,610
Average price paid per share	$	64.17	$	49.22	$	64.17	$	36.95

As of March 31, 2025, there was $78.7 million of share repurchase authorization remaining. Of the repurchases made during three and nine months ended March 31, 2025, $2.0 million or 31,337 common shares, were traded on March 31, 2025, but settled in April 2025. The Company repurchased an additional 517,600 shares for approximately $30.3 million from April 1, 2025 through April 30, 2025. The share repurchase program will continue in effect until terminated by the Board of Directors of the Company. For additional information regarding the Company’s share repurchase program, see Note 15—“Stockholders' Equity” in the 2024 Form 10-K.

On January 28, 2025, the Company entered into an equity distribution agreement pursuant to which the Company may issue and sell through distribution agents from time to time shares of the Company’s common stock in at-the-market offerings with an aggregate offering price of up to $150,000,000. The Company will issue the stock pursuant to a previously effective registration statement and a prospectus supplement filed with the SEC on January 28, 2025. No shares of the Company’s common stock have been issued pursuant to this offering.


	For the Three Months Ended March 31, 2025
(Dollars in thousands)	Unrealized gain (loss) on available-for-sale securities		Cash flow hedges		Accumulated other comprehensive income
Balance at December 31, 2024	$	(1,931)	$	4,938	$	3,007
Other comprehensive income/(loss)	588		(2,482)		(1,894)
Balance at March 31, 2025	$	(1,343)	$	2,456	$	1,113


	For the Three Months Ended March 31, 2024
(Dollars in thousands)	Unrealized gain (loss) on available-for-sale securities		Cash flow hedges		Accumulated other comprehensive income
Balance at December 31, 2023	$	(3,919)	$	—	$	(3,919)
Other comprehensive income/(loss)	855		—		855
Balance at March 31, 2024	$	(3,064)	$	—	$	(3,064)


	For the Nine Months Ended March 31, 2025
(Dollars in thousands)	Unrealized gain (loss) on available-for-sale securities		Cash flow hedges		Accumulated other comprehensive income
Balance at June 30, 2024	$	(2,466)	$	—	$	(2,466)
Other comprehensive income/(loss)	1,123		2,456		3,579
Balance at March 31, 2025	$	(1,343)	$	2,456	$	1,113


	For the Nine Months Ended March 31, 2024
(Dollars in thousands)	Unrealized gain (loss) on available-for-sale securities		Cash flow hedges		Accumulated other comprehensive income
Balance at June 30, 2023	$	(6,610)	$	—	$	(6,610)
Other comprehensive income/(loss)	3,546		—		3,546
Balance at March 31, 2024	$	(3,064)	$	—	$	(3,064)



	For the Three Months Ended March 31, 2025						For the Three Months Ended March 31, 2024
(Dollars in thousands)	Pre-tax		Tax effect		After-tax		Pre-tax		Tax effect		After-tax
Unrealized gain/(loss) on investment securities:
Net unrealized gains/(losses) arising during the period	$	850	$	(262)	$	588	$	1,211	$	(356)	$	855
Reclassification adjustment for realized (gains)/losses included in net income	—		—		—		—		—		—
Net change	$	850	$	(262)	$	588	$	1,211	$	(356)	$	855
Cash flow hedges:
Net unrealized gains/(losses) arising during the period	$	(2,464)	$	763	$	(1,701)	$	—	$	—	$	—
Reclassification adjustment for realized (gains)/losses included in net income	(1,130)		349		(781)		—		—		—
Net change	(3,594)		1,112		(2,482)		—		—		—
Total other comprehensive income/(loss)	$	(2,744)	$	850	$	(1,894)	$	1,211	$	(356)	$	855


	For the Nine Months Ended March 31, 2025						For the Nine Months Ended March 31, 2024
(Dollars in thousands)	Pre-tax		Tax effect		After-tax		Pre-tax		Tax effect		After-tax
Unrealized gain/(loss) on investment securities:
Net unrealized gains/(losses) arising during the period	$	1,581	$	(458)	$	1,123	$	5,072	$	(1,526)	$	3,546
Reclassification adjustment for realized (gains)/losses included in net income	—		—		—		—		—		—
Net change	$	1,581	$	(458)	$	1,123	$	5,072	$	(1,526)	$	3,546
Cash flow hedges:
Net unrealized gains/(losses) arising during the period	$	6,162	$	(1,904)	$	4,258	$	—	$	—	$	—
Reclassification adjustment for realized (gains)/losses included in net income	(2,608)		806		(1,802)		—		—		—
Net change	3,554		(1,098)		2,456		—		—		—
Total other comprehensive income	$	5,135	$	(1,556)	$	3,579	$	5,072	$	(1,526)	$	3,546